Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response
Its easy to find a convenient time for your online appointment, and its an affordable way to get professional recommendations on weight loss.
The patient underwent FMT infusion with material from five healthy donors and was followed for 12 months for clinical assessments, detailed descriptions of fecal microbiome composition, fecal SCFA concentration measures, and serum levels of inflammatory and neuroprotective biomarkers (Engen et al., 2020)
Effect of study bias, publication bias, and small-study effects In all analyses, the pooled estimated SMDs for the subgroups of studies deemed to have low bias was within the 95% CI of the overall (Table 4), suggesting the impact of studies with higher bias was small
US$ 29.02
US$ 27.19
US$ 24.05
US$ 24.45
US$ 28.45
